Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Capital Expenditures (2023)

Historic Capital Expenditures for Mangoceuticals (MGRX) over the last 1 years, with Q1 2023 value amounting to $3519.0.

  • Mangoceuticals' Capital Expenditures changed N/A to $3519.0 in Q1 2023 from the same period last year, while for Dec 2023 it was $3519.0, marking a year-over-year change of. This contributed to the annual value of $3519.0 for FY2023, which is N/A changed from last year.
  • As of Q1 2023, Mangoceuticals' Capital Expenditures stood at $3519.0.
  • In the past 5 years, Mangoceuticals' Capital Expenditures registered a high of $3519.0 during Q1 2023, and its lowest value of $3519.0 during Q1 2023.